The Icatibant Outcome Survey: Characterizing Breakthrough Hereditary Angioedema Attacks In Patients Receiving Long-Term Prophylaxis

被引：0

作者：

Aberer, Werner ^{[1
]}

Maurer, Marcus ^{[2
]}

Bouillet, Laurence ^{[3
]}

Perrin, Amandine ^{[4
]}

Zanichelli, Andrea ^{[5
]}

Caballero, Teresa ^{[6
]}

Longhurst, Hilary ^{[7
]}

机构：

[1] Med Univ Graz, Dept Dermatol & Venereol, Graz, Austria

[2] Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany

[3] Grenoble Univ Hosp, Natl Reference Ctr Angioedema, Dept Internal Med, Grenoble, France

[4] Shire, Eysins, Switzerland

[5] Univ Milan, Dipartimento Sci Biomed & Clin, Osped Luigi Sacco, Milan, Italy

[6] Hosp La Paz Inst Hlth Res IdiPaz, Dept Allergy, Madrid, Spain

[7] Barts Hlth NHS Trust, London, England

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2014年 / 133卷 / 02期

关键词：

D O I：

10.1016/j.jaci.2013.12.149

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

125

引用

页码：AB35 / AB35

页数：1

共 50 条

[31] Real-World Treatment Outcomes in Patients With Hereditary Angioedema Receiving Lanadelumab or Other Long-Term Prophylaxis
Lumry, William
Davis-Lorton, Mark
Soteres, Daniel
Earl, Lucy
Hall, Jennifer
Connolly, Hannah
Wynne-Cattanach, Kieran
Fox, Daniel
Sing, Krystal
Schultz, Bob
Juethner, Salome
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB75 - AB75
[32] The icatibant outcome survey: a prospective study of safety and effectiveness of icatibant in a 'real world' setting in patients with hereditary angioedema
Karon-Klefbom, M.
ALLERGY, 2010, 65 : 452 - 452
[33] Icatibant Outcome Survey in Patients with Hereditary Angioedema: Experience in Israel Compared with Other Countries
Toubi, Elias
Kivity, Shmuel
Graif, Yael
Reshef, Avner
Botha, Jaco
Andresen, Irmgard
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2018, 20 (04): : 227 - 232
[34] Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey
Maurer, M.
Bork, K.
Martinez-Saguer, I.
Aygoeren-Puersuen, E.
Botha, J.
Andresen, I.
Magerl, M.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (01) : 163 - 169
[35] Management of German hereditary angioedema patients: comparison to other regions in the icatibant outcome survey
Maurer, M.
Bork, K.
Martinez-Saguer, I
Aygoeren-Puersuen, E.
Botha, J.
Andresen, I
Magerl, M.
ALLERGY, 2018, 73 : 721 - 721
[36] Improvement in hereditary angioedema diagnosis: findings from the Icatibant Outcome Survey
Zanichelli, A.
Magerl, M.
Longhurst, H. J.
Aberer, W.
Caballero, T.
Bouillet, L.
Bygum, A.
Grumach, A. S.
Fabien, V
Andresen, I
Maurer, M.
ALLERGY, 2016, 71 : 242 - 243
[37] Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study
Caballero, Teresa
Zanichelli, Andrea
Aberer, Werner
Maurer, Marcus
Longhurst, Hilary J.
Bouillet, Laurence
Andresen, Irmgard
CLINICAL AND TRANSLATIONAL ALLERGY, 2018, 8
[38] EARLY ICATIBANT TREATMENT IS ASSOCIATED WITH FASTER RESOLUTION OF HEREDITARY ANGIOEDEMA ATTACKS: REAL-WORLD DATA FROM THE ICATIBANT OUTCOME SURVEY
Longhurst, H.
Caballero, T.
Zanichelli, A.
Aberer, W.
Fabien, V.
Bouillet, L.
Maurer, M.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A47 - A48
[39] IMPROVEMENT IN HEREDITARY ANGIOEDEMA DIAGNOSIS: FINDINGS FROM THE ICATIBANT OUTCOME SURVEY
Zanichelli, A.
Magerl, M.
Longhurst, H.
Aberer, W.
Bygum, A.
Caballero, T.
Bouillet, L.
Grumach, A.
Perrin, A.
Andresen, I.
Maurer, M.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S2 - S3
[40] LONG-TERM PROPHYLAXIS WITH SUBCUTANEOUS C1-INHIBITOR IN US PATIENTS WITH HEREDITARY ANGIOEDEMA AND VERY FREQUENT ATTACKS
Craig, T.
Zuraw, B.
Cicardi, M.
Longhurst, H.
Feuersenger, H.
Prusty, S.
Jacobs, I.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S31 - S31

← 1 2 3 4 5 →